Cardama Alfonso Quintas

Track

Insider profile

Cardama Alfonso Quintas's trades of TCR2 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
414.65
Quantity 92,995 +2.9%
Value US$974,485
Transaction date
Planned sale
Price
394.22
Quantity 72,985 +31.2%
Value US$3,189,389
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-13 2022-12-13
PlS Planned sale
92,995 +2.9%
414.65
US$974,485 		92,995 +2.9% 414.65 US$974,485
2022-12-13 2022-12-12
PlS Planned sale
280 -1.3%
122.76
US$793,515 		280 -1.3% 122.76 US$793,515
2022-12-13 2022-12-09
PlS Planned sale
72,985 +31.2%
394.22
US$3,189,389 		72,985 +31.2% 394.22 US$3,189,389
2022-12-09 2022-12-08
PlS Planned sale
4,014 -3.2%
1.26
US$5,042 		4,014 -3.2% 1.26 US$5,042
2022-12-09 2022-12-07
PlS Planned sale
3,928 -3.0%
1.28
US$5,040 		3,928 -3.0% 1.28 US$5,040
2022-12-07 2022-12-06
PlS Planned sale
3,778 -2.8%
1.33
US$5,040 		3,778 -2.8% 1.33 US$5,040
2022-12-07 2022-12-05
PlS Planned sale
3,686 -2.7%
1.37
US$5,050 		3,686 -2.7% 1.37 US$5,050
2022-12-05 2022-12-02
PlS Planned sale
3,636 -2.6%
1.39
US$5,054 		3,636 -2.6% 1.39 US$5,054